- Home
- OVID
as 06-20-2025 4:00pm EST
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 20.6M | IPO Year: | 2017 |
| Target Price: | $3.13 | AVG Volume (30 days): | 969.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.34 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.24 - $1.47 | Next Earning Date: | 08-12-2025 |
| Revenue: | $548,000 | Revenue Growth: | 15.61% |
| Revenue Growth (this year): | -43.53% | Revenue Growth (next year): | 5.32% |
Latest Ovid Therapeutics Inc. News
OVID Breaking Stock News: Dive into OVID Ticker-Specific Updates for Smart Investing
Barchart
2 days ago
Are These 2 'Strong Buy' Rated Growth Stocks Buys Right Now?
GlobeNewswire
17 days ago
Ovid Therapeutics to Host Investor and Media Event Thursday, June 12, 2025
Zacks
a month ago
Ovid Therapeutics (OVID) Reports Q1 Loss, Tops Revenue Estimates
GlobeNewswire
a month ago
Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results
Zacks
2 months ago
Ovid Therapeutics (OVID) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
GlobeNewswire
3 months ago
Ovid Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference
Simply Wall St.
3 months ago
Ovid Therapeutics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
MT Newswires
3 months ago
Wedbush Adjusts Price Target on Ovid Therapeutics to $3 From $4, Keeps Outperform Rating
Compare OVID vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OVID Ovid Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.